[15]
Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Gender inequalitiesin the promptness ofdiagnosisof bladderand renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open 2013; 3:e002861.
[16]
Horstmann M, Witthuhn R, Falk M, Stenzl A. Gender-specific differ- ences in bladder cancer: a retrospective analysis. Gend Med 2008; 5: 385–94.
[17]
Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000;55:876–80.[18]
Gakis G, Stenzl A. Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity. World J Urol 2013;31:1059–64.[19]
Wallace DM. Occupational urothelial cancer. Br J Urol 1988;61: 175–82.[20]
Dickman PW, Coviello E, Hills M.
Estimating and modelling
relative
survival using
Stata; 2012
http://pauldickman.com/rsmodel/stata_ colon/[21]
Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007;40:381–7.
[22]
Gray R. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141–54.[23]
Fajkovic H, Halpern JA, Cha EK, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011;29: 457–63.[24]
Noon AP, Albertsen PC, Thomas F, Rosario DJ, Catto JW. Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer 2013;108:1534–40.[25]
Henning A, Wehrberger M, Madersbacher S, et al. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 2013;112:68–73.[26]
Johnson EK, Daignault S, Zhang Y, Lee CT. Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 2008; 72:498–502.[27]
Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 2003;170:1765–71.[28]
Nielsen ME, Palapattu GS, Karakiewicz PI, et al. A delay in radical cystectomy of > 3 months is not associated with a worse clinical outcome. BJU Int 2007;100:1015–20.[29]
Munro NP, Sundaram SK, Weston PM, et al. A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK. Int J Radiat Oncol Biol Phys 2010;77:119–24.[30]
Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 2009;115:988–96.E U R O P E A N
U R O L O G Y
F O C U S
1
( 2 0 1 5
)
8 2 – 8 9
89




